The largest database of trusted experimental protocols

7 protocols using sc 30833

1

Histological Analysis of Molar Furcation

Check if the same lab product or an alternative is used in the 5 most similar protocols
The specimens were demineralized in 50% formic acid solution (Multichemie, Cotia, São Paulo, SP, Brazil) and 20% sodium citrate (Multichemie) in equal proportions. After this stage, the specimens were included in paraffin. Semi-serial cuts were performed in the mesio-distal direction in relation to the teeth, with a thickness of 4 µm, and the specimens were dyed with hematoxylin and eosin (HE) (Multichemie). Immunohistochemical reactions were performed using primary antibodies against TRAP (1:100, SC 30833, goat anti-TRAP, Santa Cruz Biotechnology, Dallas, TX, USA) and proteins involved in the process of bone repair in the furcation region of the first left lower molars.
+ Open protocol
+ Expand
2

Calvarial Bone Resorption Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Calvariae from 5-d-old wild-type or DKO mice were isolated aseptically, cleaned, and cultured for 16 h at 37°C in 0.5 ml of BGJb medium (Life Technologies) containing 1 mg/ml BSA (fraction V; Sigma-Aldrich; Moxon et al., 2015 (link)). Half calvariae were transferred to fresh medium with 0.1 μM parathyroid hormone (H-4835.0005; Bachem) in the presence or absence of an anti–galectin-3 monoclonal antibody (sc-32790L; Santa Cruz) or an anti-Lrp1 monoclonal antibody (MA1-27198; Thermo Fisher Scientific), and cultured for an additional 5 d. Culture supernatant was collected for bone resorption marker CTX-I level detection using RatLaps CTX-I EIA kit (AC-06F1; Immunodiagnostic Systems). The half calvariae were either fixed for immunostaining with an anti-TRAP polyclonal antibody (sc-30833; Santa Cruz), an anti–galectin-3 monoclonal antibody (#125401; Biolegend; clone M3/38), or an anti-V-type proton pump-3 (Vpp3) polyclonal antibody (ab200839; Abcam) as describe above or snap-frozen for TRAP activity assay.
+ Open protocol
+ Expand
3

Histochemical Analysis of Bone Remodeling

Check if the same lab product or an alternative is used in the 5 most similar protocols
The specimens were demineralized in 10% ethylenediaminetetraacetic acid (EDTA) and processed in a conventional manner. Semi-serial sections (4 μm) were obtained in the mesiodistal direction, and 5 equidistant sections of each specimen were stained with hematoxylin and eosin (H&E) for histological and histometric analyses. Other sections were subjected to indirect immunoperoxidase staining with the following primary antibodies: anti-tartrate-resistant acid phosphatase (anti-TRAP).(SC-30833, Santa Cruz Biotechnology, Santa Cruz, CA, USA), anti-receptor activator of nuclear factor kappa-B ligand (anti-RANKL) (SC-7628, Santa Cruz Biotechnology, Santa Cruz, CA, USA) and anti-osteoprotegerin (anti-OPG) (SC-8468, Santa Cruz Biotechnology, Santa Cruz, CA, US). The immunohistochemical processing followed the protocol described by Garcia et al., (2013) [31 (link)].
+ Open protocol
+ Expand
4

Histological Analysis of Alveolar Bone

Check if the same lab product or an alternative is used in the 5 most similar protocols
An overdose of thiopental (150 mg/kg of body weight; Cristalia, Itapira, SP, Brazil) was administered to euthanize the animals (7, 15, or 30 days after removing the ligature). The left mandibles were excised, fixed in 4% formaldehyde, and decalcified in 10% ethylenediaminetetraacetic acid solution. After tissue processing, the specimens were embedded in paraffin. Semi-serial sections cut in a disto-mesial direction, 5 µm in thickness, were obtained in a buccal-lingual sequence. The most central buccal-lingual sections of the FA of left mandibular first molars were used for histological, histomorphometric, and immunohistochemical analyses. They were either stained with hematoxylin, eosin, and phloxine for histological and histomorphometric analyses or subjected to an indirect immunoperoxidase method with the following primary antibodies: anti-tartrate-resistant acid phosphatase (TRAP) (SC30833, Santa Cruz Biotechnology, Santa Cruz, CA, USA), anti-receptor activator of nuclear factor-κB ligand (RANKL) (SC7628, Santa Cruz Biotechnology) and anti-osteoprotegerin (OPG) (SC8468, Santa Cruz Biotechnology). The immunohistochemical protocol was previously described by Nunes et al. [20 (link)].
+ Open protocol
+ Expand
5

Western Blotting Validation of HYAL1 Antibody Specificity

Check if the same lab product or an alternative is used in the 5 most similar protocols
The western blotting experiments were performed as previously described [26 (link)]. The following antibodies were used: mouse monoclonal anti-GAPDH (1:4 000 dilution, G8795, Sigma-Aldrich), anti-HYAL1 (1:1 000 dilution, 1D10, produced by hybridoma cells generously provided by B. Triggs-Raine, University of Manitoba, Winnipeg, Canada) and anti-cathepsin K (1:1 000 dilution, MAB3324, Millipore), as well as goat polyclonal anti-TRAP (1:1 000 dilution, SC-30833, Santa Cruz Biotechnology). When conditioned media were prepared, the cells were cultured for 5 h in serum-free medium prior to lysis of the cells in PBS—Triton X-100 1% supplemented with protease inhibitors (cOmplete, mini protease inhibitors cocktail, Roche). When indicated, cells were incubated for 24 h with either 15 mg/mL of mannan (Sigma-Aldrich) or 5 mM of Man-6-P (Sigma-Aldrich). In Fig 5C, cell extracts and conditioned media were treated with PNGase F (New England Biolabs) according to the manufacturer's instructions. Of note, the specificity of the anti-HYAL1 antibody was validated by an absence of signal in osteoclasts differentiated from BMM of Hyal1 -/- mice (S1A Fig). HYAL1 signals were quantified using the ImageJ (Rasband, W.S., ImageJ, U. S. National Institutes of Health, Bethesda, Maryland, USA, http://imagej.nih.gov/ij/, 1997–2015).
+ Open protocol
+ Expand
6

Immunofluorescence Staining of Cellular Markers

Check if the same lab product or an alternative is used in the 5 most similar protocols
For cell immunofluorescence staining, cells were seeded on 3.5 cm confocal dish at the density of 3 × 104. Cells were treated with or without the autophagy-flux inhibitor chloroquine (CQ) (50 μM) 3–5 h before staining. In sequence, cells were fixed with 4% paraformaldehyde at 4 °C for 10–15 min, washed with PBS, incubated with 0.5% Triton-100 at room temperature for 10 min, and blocked with PBS containing 1% BSA at room temperature for 40 min. Next, the samples were incubated with primary antibodies to LC3 (Cell Signaling Technology, 1274, 1:100), aggrecan (GeneTex, GTX54920, 1:100), collagen II (Abcam, ab34712, 1:100), OCN (Santa Cruz Biotechnology, sc-390877, 1:100), PPAR-γ (Abcam, 2435, 1:50), and TRAP (Santa Cruz Biotechnology, sc-30833, 1:100) overnight at 4 °C and subsequently incubated with fluorescent secondary antibodies, respectively. The positive cells were examined under a laser scanning confocal microscope (Olympus FluoViem FV 1000, Tokyo, Japan). Quantitative histomorphometric analysis was conducted with Image Pro Plus software.
+ Open protocol
+ Expand
7

Quantification of Osteoclasts via TRAP Staining

Check if the same lab product or an alternative is used in the 5 most similar protocols
Immunohistochemical analysis for TRAP was performed via the avidin-biotin peroxidase method using an LSAB kit according to manufacturer's instructions (Dako, Glostrup, Denmark). Six samples per group were incubated overnight with TRAP antibody diluted at 1:300 (sc-30833, Santa Cruz Biotechnology). Slides were stained with 3,3′-diaminobenzidine and counterstained with Carazzi's hematoxylin. To perform osteoclast quantification using TRAP staining, histological slides of the furcation area were evaluated under ×400 magnification. TRAP+ cells containing two or more nuclei present in the vicinity of the bone surface were considered osteoclasts. The number of osteoclasts in a furcation area in the total area of 32,400 µm 2 was counted by a trained examiner blind to the experimental groups.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!